CLIN-V · 2026
— Sector 05 · Healthcare & Life Sciences

Healthcare and Life Sciences.

Regulatory pathways, licensing, and commercial structuring for healthcare operators.

DOH licencePDPLDPA · serviceHIPAA · cross-borderCLIN-DPA-2026 · v1N 24°28′ · E 54°22′
About this sector

Commercial advice cannot be separated from regulatory compliance — patient data, clinical pathways, and operator licensing all bear on the same agreement.

Healthcare in the UAE is a sector where DOH licensing1, PDPL data-protection requirements2, HIPAA-adjacent cross-border arrangements, and operator/diagnostics service-agreement architecture3 all meet inside the same commercial document. We have advised on tripartite collaboration agreements among multinational laboratory groups, the firm's clients, and UAE health authorities; on mobile phlebotomy and home-collection service agreements; and on telemedicine cross-border data flows.

Life-sciences mandates extend the same architecture into pharmaceutical, medical-device, and clinical-trial contexts. Our work pairs the regulatory analysis with the commercial documentation, and brings in the firm's M&A and disputes capacity4 where the operator-side or product-side requires it.

In healthcare, the regulatory schedule is the contract. We draft them as one document.

— Sector V · Healthcare & Life Sciences
— References · Practice areas that bear on this sector§ Practice register

Where this sector meets our practice.

— Engaging the sector team

Discuss a healthcare and life sciences matter with us.

We're available to assess your position and advise on the most effective approach. Initial conversations are always without obligation.